Treatment was well tolerated ; confirmed renal events ( creatinine increase of 0.5 mg/dL [ > 44 umol/L ] , creatinine clearance < 50 mL/min , or level of PO4 < 2 mg/dL [ < 0.65 mmol/L ] ) were generally mild and infrequent ( < 1 % ) .